引用次数
引用: 28,310
H-指数: 49
I10-指数 : 90
出版物: 231
What is adequate radiotherapy quality assurance in phase III clinical trials involving radiation therapy?
TM Niazi , W Parulekar , M Parliament , B Cakir
RADIOTHERAPY AND ONCOLOGY 84 S29 -S29
2007
P-305/1207/Does Epidermal Growth Factor Receptor Inhibitor (EGFRI) Skin Toxicity Affect Qol? Results from a National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) Rct
HJ Au , D Goldstein , K Ding , W Parulekar
Quality of Life Research 2135 -2135
2005
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-risk HPV-related Oropharyngeal Squamous Cell Carcinoma
SV Bratman , I Karam , JN Waldron , J Butler
International Journal of Radiation Oncology, Biology, Physics 120 ( 2) S7 -S8
2024
Fundamentals of Clinical Trial Design, Conduct and Analysis
M Walker , W Parulekar , G Pond , G Smith
Fundamentals of Clinical Trial Design, Conduct and Analysis Online -Online
2017
SPIRIT 2013 statement: Defining standard protocol items for clinical trials
An Wen Chan , Jennifer M Tetzlaff , Douglas G Altman , Andreas Laupacis
Japanese pharmacology and therapeutics 45 ( 12) 1895 -1904
127
2017
Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
J Péron , P Roy , K Ding , W R Parulekar
British Journal of Cancer 112 ( 6) 971 -976
16
2015
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
Wanling Xie , Meredith M Regan , Marc Buyse , Susan Halabi
Journal of Clinical Oncology 35 ( 27) 3097 -3104
330
2017
Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey.
Brian O'Sullivan , John N. Waldron , Shao Hui Huang , Jie Su
Oral Oncology 114 105165 -105165
1
2021
Influence of the competing risk of death on estimates of disease recurrence in trials of adjuvant endocrine therapy for early-stage breast cancer: A secondary analysis of MA.27, MA.17 and MA.17R.
Josee-Lyne Ethier , Geoffrey M Anderson , Peter C Austin , Mark Clemons
European Journal of Cancer 149 117 -127
2021
Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy
Mark Frydenberg , Stephen Begbie , Xanthi Coskinas , Christopher J Sweeney
European Urology
2021
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
Malcolm J. Moore , David Goldstein , John Hamm , Arie Figer
Journal of Clinical Oncology 25 ( 15) 1960 -1966
3,105
2007
Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer
Simron Singh , Wendy Parulekar , Nevin Murray , Ronald Feld
Journal of Clinical Oncology 23 ( 4) 850 -856
79
2005
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
Padraig Warde , Malcolm Mason , Keyue Ding , Peter Kirkbride
The Lancet 378 ( 9809) 2104 -2111
641
2011
Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC).
Bingshu E Chen , Vuk Stambolic , Pamela Jean Goodwin , Wendy Parulekar
Journal of Clinical Oncology 31 1033 -1033
5
2013
Significance of baseline quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.
Michael M. Vickers , Dongsheng Tu , Chee Lee , Paul Wheatley-Price
Journal of Clinical Oncology 31 4053 -4053
1
2013
Assessment of the association of the VeriStrat test with outcomes in patients (pts) with advanced pancreatic cancer (PC) treated with gemcitabine (G) with or without erlotinib (E) in the NCIC CTG PA.3 phase III trial.
Daniel John Renouf , Wendy Parulekar , Julia Grigorieva , Dongsheng Tu
Journal of Clinical Oncology 31 ( 15) 4061 -4061
2
2013
Primary Basaloid Carcinoma of the Nipple with Associated Squamous Cell Carcinoma in Situ
Chien-Hung Chen , Caroline Rowlands , Sandip K. SenGupta , Ralph L. George
Breast Journal 15 ( 4) 409 -413
2
2009
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
Ian D Davis , Andrew J Martin , Martin R Stockler , Stephen Begbie
The New England Journal of Medicine 381 ( 2) 121 -131
899
2019
Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
Edward L. Korn , Ping-Yu Liu , Sandra J. Lee , Judith-Anne W. Chapman
Journal of Clinical Oncology 26 ( 4) 527 -534
763
2008
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
Amit Bahl , David Bottomley , Klaus Brasso , Rohit Chahal
The Lancet 396 ( 10260) 1413 -1421
188
2020